Johnson & Johnson at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Johnson & Johnson takes part in 3 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its program spans formulation and bioprocess as well as bacterial vaccines. The most concrete reports Phase 3 results from the E.mbrace study, exploring why a 9-valent vaccine (ExPEC9V) did not prevent invasive E. coli disease in older adults.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
Talk
Tue Oct 20
14:00
Track Chair
Formulation & Bioprocess
Talk
Tue Oct 20
16:00
Track Chair
Formulation & Bioprocess
Talk
Wed Oct 21
10:30

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Johnson & Johnson

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction